MAPT and Alzheimer disease: Consistent with the validity of this model, mechanisms that are engaged by the acute application of oAβ to impact synaptic plasticity, such as the involvement of GSK-3, caspase-3,17 tau,19,59 and microglia52 are all directly relevant to human AD pathology.